FDA review of dupilumab for chronic spontaneous urticaria

Published Date: 13 Mar 2023

The FDA approval request for CSU is based on data from a pair of Phase 3 trials in two different populations.

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Kidney cancer: Understanding what a renal cell carcinoma diagnosis means

2.

Why palliative care goes hand in hand with treatment for people with cancer: Q&A

3.

The discovery of drug combinations may increase the life expectancy of children with brain cancer.

4.

Trial Questions Role of Dual Immunotherapy in First-Line NSCLC

5.

Ultrasonography of hepatocellular carcinoma: From diagnosis to prognosis


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot